This page shows the latest feladilimab news and features for those working in and with pharma, biotech and healthcare.
In addition, GSK has also halted another mid-stage trial – INDUCE-4 – which is investigating feladilimab plus Keytruda and chemotherapy compared to placebo in combination with Keytruda and chemotherapy. ... Feladilimab aims to selectively enhance T
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...